[PETDAG] QoQ Quarter Result on 31-Mar-2015 [#1]

Stock
[PETDAG] PETRONAS DAGANGAN BHD
Announcement Date
11-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 46140.0%
YoY- 32.69%
Quarter Report
Latest QR
Upcoming QR
PETDAG's Result
PETDAG's Financial Summary
View:
Show?
Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 6,047,568 6,529,317 6,465,341 6,101,188 7,452,818 8,226,648 8,367,968 -19.41%
PBT 129,145 297,679 376,102 283,797 11,739 223,629 250,787 -35.67%
Tax -36,826 -77,362 -101,643 -76,268 -11,114 -61,721 -62,363 -29.54%
NP 92,319 220,317 274,459 207,529 625 161,908 188,424 -37.76%
-
NP to SH 92,113 218,884 273,210 205,768 445 160,399 185,649 -37.24%
-
Tax Rate 28.52% 25.99% 27.03% 26.87% 94.68% 27.60% 24.87% -
Total Cost 5,955,249 6,309,000 6,190,882 5,893,659 7,452,193 8,064,740 8,179,544 -19.02%
-
Net Worth 4,947,400 4,997,073 4,897,728 4,748,710 4,748,710 4,857,989 4,828,186 1.63%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div 198,690 139,083 139,083 119,214 218,559 119,214 139,083 26.76%
Div Payout % 215.70% 63.54% 50.91% 57.94% 49,114.58% 74.32% 74.92% -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 4,947,400 4,997,073 4,897,728 4,748,710 4,748,710 4,857,989 4,828,186 1.63%
NOSH 993,454 993,454 993,454 993,454 993,454 993,454 993,454 0.00%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 1.53% 3.37% 4.25% 3.40% 0.01% 1.97% 2.25% -
ROE 1.86% 4.38% 5.58% 4.33% 0.01% 3.30% 3.85% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 608.74 657.23 650.79 614.14 750.19 828.09 842.31 -19.41%
EPS 9.30 22.00 27.50 20.70 0.04 16.10 18.70 -37.14%
DPS 20.00 14.00 14.00 12.00 22.00 12.00 14.00 26.76%
NAPS 4.98 5.03 4.93 4.78 4.78 4.89 4.86 1.63%
Adjusted Per Share Value based on latest NOSH - 993,454
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 608.74 657.23 650.79 614.14 750.19 828.09 842.31 -19.41%
EPS 9.30 22.00 27.50 20.70 0.04 16.10 18.70 -37.14%
DPS 20.00 14.00 14.00 12.00 22.00 12.00 14.00 26.76%
NAPS 4.98 5.03 4.93 4.78 4.78 4.89 4.86 1.63%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 24.86 21.82 20.58 20.00 17.12 20.00 24.04 -
P/RPS 4.08 3.32 3.16 3.26 2.28 2.42 2.85 26.93%
P/EPS 268.12 99.03 74.83 96.56 38,220.07 123.87 128.64 62.95%
EY 0.37 1.01 1.34 1.04 0.00 0.81 0.78 -39.09%
DY 0.80 0.64 0.68 0.60 1.29 0.60 0.58 23.83%
P/NAPS 4.99 4.34 4.17 4.18 3.58 4.09 4.95 0.53%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 19/02/16 02/11/15 06/08/15 11/05/15 12/02/15 04/11/14 07/08/14 -
Price 25.40 22.50 21.44 21.64 17.00 20.50 20.00 -
P/RPS 4.17 3.42 3.29 3.52 2.27 2.48 2.37 45.59%
P/EPS 273.94 102.12 77.96 104.48 37,952.18 126.97 107.02 86.80%
EY 0.37 0.98 1.28 0.96 0.00 0.79 0.93 -45.81%
DY 0.79 0.62 0.65 0.55 1.29 0.59 0.70 8.37%
P/NAPS 5.10 4.47 4.35 4.53 3.56 4.19 4.12 15.24%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment